ARDX insider buying and SEC filings, explained
Ardelyx, Inc. · CIK 1437402
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- NTERYX INC
Insider activity in the last 12 months
Bought
$1.9M
Insiders who bought
1
Sold (not marked 10b5-1)
$2.0M
Planned sales (10b5-1)
$2.3M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 21, 2026 | Sale | Susan Hohenleitner (CFO) sold 1,558 shares at about $3.86 ($6K). Holdings down 1% to 227,520 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | James Parker Brady (Chief Human Resources Officer) sold 15,136 shares at about $3.86 ($58K). Holdings down 6% to 245,930 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Joseph James Reilly (Chief Accounting Officer) sold 3,982 shares at about $3.86 ($15K). Holdings down 3% to 145,854 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Eric Duane Foster (Chief Commercial Officer) sold 8,562 shares at about $3.86 ($33K). Holdings down 2% to 409,410 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Mike Kelliher (Chief Business Officer) sold 7,758 shares at about $3.86 ($30K). Holdings down 2% to 349,660 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Laura A Williams (Chief Patient Officer) sold 10,739 shares at about $3.86 ($41K). Holdings down 3% to 367,456 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Michael Raab (CEO and Director) sold 58,574 shares at about $3.86 ($226K). Holdings down 3% to 1,619,792 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | John E Bishop (Chief Technical and Quality Officer) sold 19,750 shares at about $3.86 ($76K). Holdings down 6% to 317,095 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Jul 15, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,668 shares at about $5.06 ($211K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,678,366 shares. | SEC filing Filed Jul 17, 2026 |
| Jun 18, 2026 | Planned (10b5-1) | Laura A Williams (Chief Patient Officer) sold 81,898 shares at about $5.99 ($491K), marked as a 10b5-1 plan trade. Holdings down 18% to 378,195 shares. | SEC filing Filed Jun 22, 2026 |
| Jun 15, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,666 shares at about $5.67 ($236K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,699,200 shares. | SEC filing Filed Jun 17, 2026 |
| May 21, 2026 | Sale | Susan Hohenleitner (CFO) sold 1,455 shares at $6.27 ($9K). Holdings down 1% to 229,078 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | James Parker Brady (Chief Human Resources Officer) sold 1,846 shares at $6.27 ($12K). Holdings down 1% to 261,066 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | Joseph James Reilly (Chief Accounting Officer) sold 3,719 shares at $6.27 ($23K). Holdings down 2% to 149,836 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | Eric Duane Foster (Chief Commercial Officer) sold 7,998 shares at $6.27 ($50K). Holdings down 2% to 417,972 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | Mike Kelliher (Chief Business Officer) sold 7,248 shares at $6.27 ($45K). Holdings down 2% to 357,418 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | Laura A Williams (Chief Patient Officer) sold 6,989 shares at $6.27 ($44K). Holdings down 2% to 429,093 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | Michael Raab (CEO and Director) sold 54,748 shares at $6.27 ($343K). Holdings down 3% to 1,720,033 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 21, 2026 | Sale | John E Bishop (Chief Technical and Quality Officer) sold 2,306 shares at $6.27 ($14K). Holdings down 1% to 336,845 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 15, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,666 shares at about $6.28 ($262K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,774,781 shares. | SEC filing Filed May 19, 2026 |
| Apr 15, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,668 shares at about $6.29 ($262K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,795,614 shares. | SEC filing Filed Apr 17, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,666 shares at about $5.84 ($243K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,816,448 shares. | SEC filing Filed Mar 18, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Michael Raab (CEO and Director) sold 41,666 shares at about $6.26 ($261K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,836,153 shares. | SEC filing Filed Feb 25, 2026 |
| Feb 20, 2026 | Purchase (code P) | David M. Mott (Director) bought 333,333 shares at about $5.84 ($1.9M), reported as a purchase (code P). Holdings up 11% to 3,302,918 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | John E Bishop (Chief Technical Operations Officer) sold 3,179 shares at about $5.85 ($19K). Holdings down 1% to 339,151 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Joseph James Reilly (Chief Accounting Officer) sold 4,991 shares at about $5.85 ($29K). Holdings down 3% to 151,790 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Laura A Williams (Chief Patient Officer) sold 8,176 shares at about $5.85 ($48K). Holdings down 2% to 436,082 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Susan Hohenleitner (CFO) sold 2,033 shares at about $5.85 ($12K). Holdings down 1% to 230,533 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | James Parker Brady (Chief Human Resources Officer) sold 2,543 shares at about $5.85 ($15K). Holdings down 1% to 262,912 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Mike Kelliher (Chief Business Officer) sold 9,595 shares at about $5.85 ($56K). Holdings down 3% to 364,666 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Michael Raab (CEO and Director) sold 45,982 shares at about $5.85 ($269K). Holdings down 2% to 1,856,986 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 20, 2026 | Sale | Eric Duane Foster (Chief Commercial Officer) sold 10,439 shares at about $5.85 ($61K). Holdings down 2% to 425,970 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Jan 8, 2026 | Planned (10b5-1) | Laura A Williams (Chief Patient Officer) sold 50,000 shares at about $6.98 ($349K), marked as a 10b5-1 plan trade. Holdings down 12% to 361,563 shares. | SEC filing Filed Jan 9, 2026 |
| Nov 21, 2025 | Sale | Elizabeth A. Grammer (Chief Legal and Administrative Officer) sold 5,995 shares at $5.54 ($33K). Holdings down 2% to 299,895 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Sale | Michael Raab (CEO and Director) sold 46,887 shares at $5.54 ($260K). Holdings down 3% to 1,455,363 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Sale | Mike Kelliher (Chief Business Officer) sold 5,560 shares at $5.54 ($31K). Holdings down 2% to 271,181 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Sale | Laura A Williams (Chief Patient Officer) sold 6,426 shares at $5.54 ($36K). Holdings down 2% to 359,896 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Sale | Eric Duane Foster (Chief Commercial Officer) sold 5,814 shares at $5.54 ($32K). Holdings down 2% to 295,684 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
| Nov 21, 2025 | Sale | Joseph James Reilly (Officer) sold 11,086 shares at $5.54 ($61K). Holdings down 9% to 108,914 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
23 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:03 PM ET 8-K | Earnings released (Item 2.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ARDX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.